208 related articles for article (PubMed ID: 20066732)
1. Tube feeding, the microbiota, and Clostridium difficile infection.
O'Keefe SJ
World J Gastroenterol; 2010 Jan; 16(2):139-42. PubMed ID: 20066732
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for Clostridium difficile-associated diarrhea and the effectiveness of prophylactic probiotic therapy.
Mizui T; Teramachi H; Tachi T; Tamura K; Shiga H; Komada N; Umeda M; Koda A; Aoyama S; Goto C; Tsuchiya T
Pharmazie; 2013 Aug; 68(8):706-10. PubMed ID: 24020129
[TBL] [Abstract][Full Text] [Related]
3. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR
Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510
[TBL] [Abstract][Full Text] [Related]
4. Does PPI therapy predispose to Clostridium difficile infection?
Pant C; Madonia P; Minocha A
Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):555-7. PubMed ID: 19713988
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiology of Clostridium difficile infection].
Szczesny A; Martirosian G
Przegl Epidemiol; 2002; 56(1):49-56. PubMed ID: 12150067
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile associated infection, diarrhea and colitis.
Hookman P; Barkin JS
World J Gastroenterol; 2009 Apr; 15(13):1554-80. PubMed ID: 19340897
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile colitis: an increasing hospital-acquired illness.
Jobe BA; Grasley A; Deveney KE; Deveney CW; Sheppard BC
Am J Surg; 1995 May; 169(5):480-3. PubMed ID: 7747823
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and typing of Clostridium difficile.
Jumaa P; Wren B; Tabaqchali S
Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1035-40. PubMed ID: 8944362
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile colitis: a review.
Moudgal V; Sobel JD
Hosp Pract (1995); 2012 Feb; 40(1):139-48. PubMed ID: 22406889
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with nosocomial diarrhea and Clostridium difficile-associated disease on the adult wards of an urban tertiary care hospital.
Schwaber MJ; Simhon A; Block C; Roval V; Ferderber N; Shapiro M
Eur J Clin Microbiol Infect Dis; 2000 Jan; 19(1):9-15. PubMed ID: 11699546
[TBL] [Abstract][Full Text] [Related]
11. "Collateral damage": antibiotics and the risk of Clostridium difficile infection.
Yam FK; Smith KM
Orthopedics; 2005 Mar; 28(3):275-9. PubMed ID: 15790086
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004.
Barbut F; Gariazzo B; Bonné L; Lalande V; Burghoffer B; Luiuz R; Petit JC
Infect Control Hosp Epidemiol; 2007 Feb; 28(2):131-9. PubMed ID: 17265393
[TBL] [Abstract][Full Text] [Related]
13. Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study.
Hong SH; Lee EK; Shin JY
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):479-488. PubMed ID: 30848536
[TBL] [Abstract][Full Text] [Related]
14. Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation.
Vesta KS; Wells PG; Gentry CA; Stipek WJ
Am J Infect Control; 2005 Oct; 33(8):469-72. PubMed ID: 16216661
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding.
Bliss DZ; Johnson S; Savik K; Clabots CR; Willard K; Gerding DN
Ann Intern Med; 1998 Dec; 129(12):1012-9. PubMed ID: 9867755
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile acquisition rate and its role in nosocomial diarrhoea at a university hospital in Turkey.
Söyletir G; Eskitürk A; Kiliç G; Korten V; Tözün N
Eur J Epidemiol; 1996 Aug; 12(4):391-4. PubMed ID: 8891544
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiology of Clostridium difficile nosocomial infections].
Barbut F; Petit JC
Presse Med; 1996 Mar 2-9; 25(8):385-92. PubMed ID: 8685186
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics of Clostridium difficile infection in a high complexity hospital and report of the circulation of the NAP1/027 hypervirulent strain in Colombia].
Gualtero SM; Abril LA; Camelo N; Sanchez SD; Davila FA; Arias G; Silva E; Bustos IG; Josa DF; Torres IC; Zambrano LC; Pareja MJ
Biomedica; 2017 Dec; 37(4):466-472. PubMed ID: 29373767
[TBL] [Abstract][Full Text] [Related]
19. A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity.
Gebhart D; Lok S; Clare S; Tomas M; Stares M; Scholl D; Donskey CJ; Lawley TD; Govoni GR
mBio; 2015 Mar; 6(2):. PubMed ID: 25805733
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
Labbé AC; Poirier L; Maccannell D; Louie T; Savoie M; Béliveau C; Laverdière M; Pépin J
Antimicrob Agents Chemother; 2008 Sep; 52(9):3180-7. PubMed ID: 18573937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
